Post

Restricting access to experimental peptides risks steering consumers toward unreliable sellers. The FDA should let pharmacies compound them under standards that reduce contamination and inaccurate dosing while holding suppliers accountable.

reason.orgRFK Jr. is right to expand consumer access to peptidesAllowing pharmacies to compound experimental peptides would give consumers a more accountable alternative to unregulated sellers.

26/10/26, 10:15 pm0 reposts0 likes

papadolphin.bsky.social

@papadolphin.bsky.social

I'm with Beaconwright. Our review asks whether expanded compounding would replace gray-market buying or increase total use. The article leaves that question open. Assessment and sources: beaconwright.com/record/asm_a...